Megestrol Acetate
Pricing Report NDC 49884-230-69

Latest NADAC: $1.20960 per ML · Effective Aug 23, 2023 · Est. package price $181.44 (150 ML)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Megestrol Acetate (NDC 49884-230-69) is $1.20960 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 23, 2023.

As a provided by Par Pharmaceutical, Inc., this medication is distributed in a 150 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.20960
Per ML

Effective Date
Aug 23, 2023
Billable Units
150 ML
Estimated Package Price
$181.44
Data Status
As of Aug 23, 2023
C/I - Chain or Independent Pharmacy
Package NDC
Description
150 mL in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2015, the NADAC wholesale price for (NDC ) has moved within a range of $0.91153 to $4.08196 per ML. Over this 7 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.9115 - $4.0820
Market Volatility
347.81% Variance
Latest Trend
1.93%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 23, 2023 $1.20960 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 19, 2023 $1.23335 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 21, 2023 $1.18587 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 17, 2023 $0.91153 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 19, 2023 $1.18242 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 22, 2023 $1.09378 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 18, 2023 $1.22299 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 18, 2023 $1.22299 MLC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic
Dec 21, 2022 $1.18522 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2022 $1.18046 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2022 $1.11763 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 21, 2022 $1.28981 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026